Source:http://linkedlifedata.com/resource/pubmed/id/12402501
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2002-10-29
|
pubmed:abstractText |
The kynurenine pathway is the main pathway for tryptophan metabolism. It generates compounds that can modulate activity at glutamate receptors and possibly nicotinic receptors, in addition to some as-yet-unidentified sites. The pathway is in a unique position to regulate other aspects of the metabolism of tryptophan to neuroactive compounds, and also seems to be a key factor in the communication between the nervous and immune systems. It also has potentially important roles in the regulation of cell proliferation and tissue function in the periphery. As a result, the pathway presents a multitude of potential sites for drug discovery in neuroscience, oncology and visceral pathology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1474-1776
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
609-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12402501-Animals,
pubmed-meshheading:12402501-Drug Delivery Systems,
pubmed-meshheading:12402501-Drug Design,
pubmed-meshheading:12402501-Humans,
pubmed-meshheading:12402501-Kynurenic Acid,
pubmed-meshheading:12402501-Kynurenine,
pubmed-meshheading:12402501-Signal Transduction,
pubmed-meshheading:12402501-Technology, Pharmaceutical,
pubmed-meshheading:12402501-Tryptophan
|
pubmed:year |
2002
|
pubmed:articleTitle |
Endogenous kynurenines as targets for drug discovery and development.
|
pubmed:affiliation |
Institute of Biomedical and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12 8QQ, UK. T.W.Stone@bio.gla.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|